Ā | Intervention group | Usual care group | ||
---|---|---|---|---|
Ā | n | % | n | % |
Education | Ā | Ā | Ā | Ā |
āLow | 4 | 3.9 | 18 | 17.6 |
āMedium | 48 | 47.1 | 42 | 41.2 |
āHigh | 47 | 46.1 | 36 | 35.3 |
āUnknown | 3 | 2.9 | 6 | 5.9 |
Marital status | Ā | Ā | Ā | Ā |
āCouple | 79 | 77.5 | 76 | 74.5 |
āSingle | 20 | 19.6 | 20 | 19.6 |
āUnknown | 3 | 2.9 | 6 | 5.9 |
Menopausal status | Ā | Ā | Ā | Ā |
āPremenopausal | 48 | 47.1 | 67 | 65.7 |
āPostmenopausal | 45 | 44.1 | 33 | 32.4 |
āUnknown | 9 | 8.8 | 2 | 2.0 |
Radiotherapy | Ā | Ā | Ā | Ā |
āNo | 30 | 29.4 | 33 | 32.4 |
āYes | 72 | 70.6 | 69 | 67.6 |
Tissue expander | Ā | Ā | Ā | Ā |
āNo | 93 | 91.2 | 92 | 90.2 |
āYes | 9 | 8.8 | 10 | 9.8 |
Her2, ER, and PR receptors | Ā | Ā | Ā | Ā |
āTriple negative | 24 | 23.5 | 12 | 11.8 |
āHer2Neu+, ER+, or PR+ | 11 | 10.8 | 18 | 17.6 |
āHer2Neu+, ERā, and PRā | 10 | 9.8 | 2 | 2.0 |
āHer2Neuā, ER+, or PR+ | 57 | 55.9 | 70 | 68.6 |
Adjuvant treatment started before recruitment | Ā | Ā | Ā | Ā |
āChemotherapy | 36 | 35.3 | 36 | 35.3 |
āRadiotherapy | 27 | 26.5 | 35 | 34.3 |
āNone | 39 | 38.2 | 31 | 30.4 |
Ā | Mean | SD | Mean | SD |
Age (years) | 49.7 | 8.2 | 49.5 | 7.9 |
Height (cm) | 168.1 | 6.6 | 169.1 | 6.5 |
Weight (kg) | 72.8 | 13.2 | 76.0 | 15.4 |
BMI (kg/m2) | 25.8 | 4.4 | 26.6 | 5.2 |
Ā | Median | IQR | Median | IQR |
Moderate to high intensity total PA performed before diagnosis (min/week)* | 485 | 240ā975 | 600 | 300ā1440 |
Moderate to high intensity leisure and sport PA performed before diagnosis (min/week) | 180 | 50ā375 | 173 | 60ā330 |